Bayer and the University of Texas MD Anderson Cancer Center have signed a five-year collaboration agreement to accelerate the development of novel targeted treatments for cancer.
What does the cutting-edge of digital health look like? Which innovations are on the cusp of becoming a mainstream reality and who is it that is driving this advancement?
A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.